Let’s dig into the relative performance of Constellation Brands (NYSE: STZ) and its peers as we unravel the now-completed Q4 beverages, alcohol, and tobacco earnings season.

These companies' performance is influenced by brand strength, marketing strategies, and shifts in consumer preferences. Changing consumption patterns are particularly relevant and can be seen in the rise of cannabis, craft beer, and vaping or the steady decline of soda and cigarettes. Companies that spend on innovation to meet consumers where they are with regards to trends can reap huge demand benefits while those who ignore trends can see stagnant volumes. Finally, with the advent of the social media, the cost of starting a brand from scratch is much lower, meaning that new entrants can chip away at the market shares of established players.

The 14 beverages, alcohol, and tobacco stocks we track reported a mixed Q4. As a group, revenues beat analysts’ consensus estimates by 1.3% while next quarter’s revenue guidance was 0.6% below.

While some beverages, alcohol, and tobacco stocks have fared somewhat better than others, they have collectively declined. On average, share prices are down 3% since the latest earnings results.

Weakest Q4: Constellation Brands (NYSE: STZ)

With a presence in more than 100 countries, Constellation Brands (NYSE: STZ) is a globally renowned producer and marketer of beer, wine, and spirits.

Constellation Brands reported revenues of $2.46 billion, flat year on year. This print fell short of analysts’ expectations by 2.7%. Overall, it was a slower quarter for the company with a miss of analysts’ organic revenue and adjusted operating income estimates.

The stock is down 20.1% since reporting and currently trades at $175.04.

Read our full report on Constellation Brands here, it’s free.

Best Q4: Celsius (NASDAQ: CELH)

With its proprietary MetaPlus formula as the basis for key products, Celsius (NASDAQ: CELH) offers energy drinks that feature natural ingredients to help in fitness and weight management.

Celsius reported revenues of $332.2 million, down 4.4% year on year, outperforming analysts’ expectations by 2.7%. The business had a strong quarter with an impressive beat of analysts’ EBITDA estimates and a solid beat of analysts’ adjusted operating income estimates.

However, the results were likely priced into the stock as it’s traded sideways since reporting. Shares currently sit at $25.74.

Is now the time to buy Celsius? Access our full analysis of the earnings results here, it’s free.

Monster (NASDAQ: MNST)

Founded in 2002 as a natural soda and juice company, Monster Beverage (NASDAQ: MNST) is a pioneer of the energy drink category, and its Monster Energy brand targets a young, active demographic.

Monster reported revenues of $1.81 billion, up 4.7% year on year, exceeding analysts’ expectations by 0.7%. Still, it was a slower quarter as it posted a significant miss of analysts’ EBITDA estimates and a miss of analysts’ EPS estimates.

Interestingly, the stock is up 6.2% since the results and currently trades at $55.10.

Read our full analysis of Monster’s results here.

Coca-Cola (NYSE: KO)

A pioneer and behemoth in carbonated soft drinks, Coca-Cola (NYSE: KO) is a storied beverage company best known for its flagship soda.

Coca-Cola reported revenues of $11.4 billion, up 4.2% year on year. This result beat analysts’ expectations by 6.5%. It was a very strong quarter as it also produced a solid beat of analysts’ organic revenue estimates and a decent beat of analysts’ EBITDA estimates.

Coca-Cola scored the biggest analyst estimates beat among its peers. The stock is up 12% since reporting and currently trades at $72.30.

Read our full, actionable report on Coca-Cola here, it’s free.

Zevia (NYSE: ZVIA)

With a primary focus on soda but also a presence in energy drinks and teas, Zevia (NYSE: ZVIA) is a better-for-you beverage company.

Zevia reported revenues of $39.46 million, up 4.4% year on year. This number met analysts’ expectations. However, it was a softer quarter as it logged full-year EBITDA guidance missing analysts’ expectations.

The stock is down 28.6% since reporting and currently trades at $2.32.

Read our full, actionable report on Zevia here, it’s free.

Want to invest in winners with rock-solid fundamentals? Check out our 9 Best Market-Beating Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate.

Join Paid Stock Investor Research

Help us make StockStory more helpful to investors like yourself. Join our paid user research session and receive a $50 Amazon gift card for your opinions. Sign up here.